Gunter Weisshaar - Tecan Group Head VP
TCHBF Stock | USD 277.00 0.00 0.00% |
Insider
Gunter Weisshaar is Head VP of Tecan Group
Age | 63 |
Phone | 41 44 922 88 88 |
Web | https://www.tecan.com |
Tecan Group Management Efficiency
The company has return on total asset (ROA) of 0.0488 % which means that it generated a profit of $0.0488 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0981 %, meaning that it generated $0.0981 on every $100 dollars invested by stockholders. Tecan Group's management efficiency ratios could be used to measure how well Tecan Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Justin Leong | ResMed Inc | 47 | |
Eyal MD | Microbot Medical | 59 | |
Vered Keisar | ResMed Inc | N/A | |
Kimberly MacKay | West Pharmaceutical Services | 58 | |
FACC MD | Becton Dickinson and | N/A | |
Joanne Egamino | STAAR Surgical | N/A | |
Samrat Esq | Becton Dickinson and | 57 | |
Ching leong | Becton Dickinson and | 53 | |
Troy Kirkpatrick | Becton Dickinson and | N/A | |
Pr DSc | Microbot Medical | 72 | |
Constance Bienfait | ResMed Inc | N/A | |
Rajwant Sodhi | ResMed Inc | 46 | |
Carrie Byington | Becton Dickinson and | 57 | |
AM AM | ResMed Inc | 80 | |
Robert Segura | West Pharmaceutical Services | N/A | |
Amy Wakeham | ResMed Inc | N/A | |
Rachel Vaknin | Microbot Medical | 45 | |
Scott MD | STAAR Surgical | 61 | |
Francesca DeMartino | Becton Dickinson and | N/A | |
Patrick Williams | STAAR Surgical | 51 | |
BE MBA | ResMed Inc | 50 |
Management Performance
Return On Equity | 0.0981 | |||
Return On Asset | 0.0488 |
Tecan Group Leadership Team
Elected by the shareholders, the Tecan Group's board of directors comprises two types of representatives: Tecan Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tecan. The board's role is to monitor Tecan Group's management team and ensure that shareholders' interests are well served. Tecan Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tecan Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Achim Leoprechting, Executive Vice President Head of the Partnering Business division, Member of the Management Board | ||
Wael Yared, Ex CTO | ||
Ralf Griebel, Head VP | ||
Andreas Wilhelm, Executive VP, General Counsel, Secretary and Member of Management Board | ||
Martin Brandle, Sr Board | ||
MBA MSc, Member VP | ||
Gunter Weisshaar, Head VP | ||
Ulrich Kanter, Executive Vice President Head of the Division Development and Operations, Member of the Management Board |
Tecan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tecan Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0981 | |||
Return On Asset | 0.0488 | |||
Profit Margin | 0.1 % | |||
Operating Margin | 0.12 % | |||
Current Valuation | 5.68 B | |||
Shares Outstanding | 12.73 M | |||
Shares Owned By Insiders | 0.37 % | |||
Shares Owned By Institutions | 71.47 % | |||
Price To Earning | 36.37 X | |||
Price To Book | 3.63 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Tecan Pink Sheet
Tecan Group financial ratios help investors to determine whether Tecan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tecan with respect to the benefits of owning Tecan Group security.